Bank of America Cuts Neumora Therapeutics (NASDAQ:NMRA) Price Target to $7.00
Neumora Therapeutics (NASDAQ:NMRA – Free Report) had its price target reduced by Bank of America from $22.00 to $7.00 in a report released on Monday,Benzinga reports. They currently have a buy rating on the stock. Several other equities research analysts have also commented on the company. JPMorgan Chase & Co. lowered Neumora Therapeutics from an […]
More Stories
Cousins Properties (NYSE:CUZ) Stock Rating Lowered by StockNews.com
Cousins Properties (NYSE:CUZ – Get Free Report) was downgraded by investment analysts at StockNews.com from a “hold” rating to a...
Mohawk Industries (NYSE:MHK) Upgraded at StockNews.com
Mohawk Industries (NYSE:MHK – Get Free Report) was upgraded by investment analysts at StockNews.com from a “hold” rating to a...
StockNews.com Upgrades Viavi Solutions (NASDAQ:VIAV) to “Buy”
Viavi Solutions (NASDAQ:VIAV – Get Free Report) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy”...
Wishbone Gold (LON:WSBN) Stock Price Down 4.2% – Should You Sell?
Shares of Wishbone Gold Plc (LON:WSBN – Get Free Report) dropped 4.2% during trading on Thursday . The company traded...
Aurinia Pharmaceuticals (NASDAQ:AUPH) Rating Increased to Strong-Buy at StockNews.com
Aurinia Pharmaceuticals (NASDAQ:AUPH – Get Free Report) (TSE:AUP) was upgraded by stock analysts at StockNews.com from a “buy” rating to...
Shoe Zone (LON:SHOE) Stock Passes Below 50-Day Moving Average – Here’s What Happened
Shares of Shoe Zone plc (LON:SHOE – Get Free Report) crossed below its fifty day moving average during trading on...